Asset Details
Do you wish to reserve the book?
Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions
Do you wish to request the book?
Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions
2010
Overview
Sociological interest in Pharmaceuticals has intensified, heightening awareness of 'pharmaceuticalization'. It is argued that pharmaceuticalization should be understood by reference to five main biosociological explanatory factors: biomedicalism, medicalization, pharmaceutical industry promotion and marketing, consumerism, and regulatory-state ideology or policy. The biomedicalism thesis, which claims that expansion of drug treatment reflects advances in biomedicai science to meet health needs, is found to be a weak explanatory factor because a significant amount of growth in pharmaceuticalization is inconsistent with scientific evidence, and because drug innovations offering significant therapeutic advance have been declining across the sector including areas of major health need. Some elements of consumerism have undermined pharmaceuticalization, even causing de-pharmaceuticalization in some therapeutic sub-fields. However; other aspects of consumerism, together with industry promotion, medicalization, and deregulatory state policies are found to be drivers of increased pharmaceuticalization in ways that are largely outside, or suboptimal fon significant therapeutic advances in the interests of public health.
